Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Kranjc, Zofija
DOB:	16-JUN-1941 (Age: 84)
Gender:	female
Address:	Kremžarjeva ulica 8 5271 Vipava (Slovenia)
ID:	8388-709159-9 (ECI)

Report
Date:	30-JAN-2018

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Zdravstveni Dom Sežana Partizanska cesta 24,26 6210 Sežana (Slovenia)

Specimen
Collected:	30-JAN-2018

Hematology

Test	30-JAN-2018	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	3.5 L	4.0 - 11.0	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	4.6	4.0 - 5.2	10*6/uL
Hemoglobin [Mass/volume] in Blood	13.7	12 - 16	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	43.4	36 - 46	%
MCV [Entitic mean volume] in Red Blood Cells by Automated count	87.5	80 - 100	fL
MCH [Entitic mass] by Automated count	30.8	27 - 33	pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count	36.0	32.0 - 36.0	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	40.7	36 - 47	fL
Platelets [#/volume] in Blood by Automated count	243.1	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	263.5 H	9.4 - 12.3	fL
Platelet [Entitic mean volume] in Blood by Automated count	12.3 H	7.2 - 11.1	fL

Chemistry

Test	30-JAN-2018	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.4	4.8 - 5.9	%
Glucose [Mass/volume] in Blood	85.6	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	19.7	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.6	0.5 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	10.2	8.6 - 10.3	mg/dL
Sodium [Moles/volume] in Blood	136.9	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	5.1	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	101.7	96 - 106	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	23.9	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	213.3 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	125.9	0 - 149	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	122.4 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	65.7	40 - 90	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	8.3	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Most parameters are within normal limits. Notable findings include mildly elevated total and LDL cholesterol, which may increase cardiovascular risk, and a low leukocyte count, which could indicate mild leukopenia—monitor for infection or bone marrow suppression. Platelet indices (PDW and MPV) are elevated, possibly reflecting increased platelet turnover or activation. No evidence of renal dysfunction or diabetes. Recommend clinical correlation and follow-up as appropriate.

Conclusion and Recommendations based on this report and previous findings known to us

Most parameters are within normal limits. Notable findings include mildly elevated total and LDL cholesterol, which may increase cardiovascular risk, and a low leukocyte count, which could indicate mild leukopenia—monitor for infection or bone marrow suppression. Platelet indices (PDW and MPV) are elevated, possibly reflecting increased platelet turnover or activation. No evidence of renal dysfunction or diabetes. Recommend clinical correlation and follow-up as appropriate.